TY  - GEN
AU  - Pieniaszek,Henry J
AU  - Sy,Sherwin K B
AU  - Ebling,William
AU  - Fossler,Michael J
AU  - Cain,Valerie A
AU  - Mondick,John T
AU  - Ma,Su
AU  - Kornhauser,David M
TI  - Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers
SN  - 0091-2700
PY  - 2003///0210
KW  - Administration, Oral
KW  - Adolescent
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Amidines
KW  - administration & dosage
KW  - Amino Acids
KW  - blood
KW  - Area Under Curve
KW  - Aspirin
KW  - pharmacology
KW  - Bleeding Time
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Interactions
KW  - Female
KW  - Humans
KW  - Hydrolysis
KW  - Isoxazoles
KW  - Male
KW  - Middle Aged
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Prodrugs
KW  - Time Factors
N1  - Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
UR  - https://doi.org/10.1177/009127002401102687
ER  -